David Southwell

2023

In 2023, David Southwell earned a total compensation of $1.3M as Former President, Chief Executive Officer and Director at TScan Therapeutics, a 40% decrease compared to previous year.

Compensation breakdown

Option Awards$135,250
Salary$153,472
Other$1,003,724
Total$1,292,446

Southwell received $1M in other compensation, accounting for 78% of the total pay in 2023.

Southwell also received $135.3K in option awards and $153.5K in salary.

Rankings

In 2023, David Southwell's compensation ranked 928th out of 2,918 executives tracked by ExecPay. In other words, Southwell earned more than 68.2% of executives.

ClassificationRankingPercentile
All
928
out of 2,918
68th
Division
Manufacturing
552
out of 1,608
66th
Major group
Chemicals And Allied Products
376
out of 901
58th
Industry group
Drugs
365
out of 864
58th
Industry
Biological Products, Except Diagnostic Substances
113
out of 211
46th
Source: SEC filing on April 30, 2024.

Southwell's colleagues

We found four more compensation records of executives who worked with David Southwell at TScan Therapeutics in 2023.

2023

Gavin MacBeath

TScan Therapeutics

Chief Executive Officer

2023

Debora Barton

TScan Therapeutics

Chief Medical Officer

2023

Brian Silver

TScan Therapeutics

Chief Financial Officer

2023

Zoran Zdraveski

TScan Therapeutics

Secretary

News

You may also like